Nicole Sweeny - 12 Jan 2023 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Chief Commercial Officer
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Issuer symbol
PRAX
Transactions as of
12 Jan 2023
Net transactions value
$0
Form type
4
Filing time
13 Jan 2023, 06:45:18 UTC
Previous filing
09 Jan 2023
Next filing
13 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRAX Stock Option (Right to Buy) Award $0 +41,085 $0.000000 41,085 12 Jan 2023 Common Stock 41,085 $2.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ms. Sweeny opted to receive this option grant in lieu of a cash bonus for the fiscal year ended December 31, 2022.